시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
마이코플라스마 검사 시장 규모, 점유율, 성장 분석, 제품 및 서비스별, 방법별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)
Mycoplasma Testing Market Size, Share, Growth Analysis, By Product & Service, By Technique, By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드 : 1563371
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2024년 09월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,483,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,754,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,025,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계 마이코플라스마 검사 시장 규모는 2022년 8억 2,960만 달러에서 2023년 9억 1,023만 달러, 2031년에는 19억 1,178만 달러로 예측 기간(2024-2031년) 동안 9.72%의 CAGR로 성장할 것으로 예상됩니다.

마이코플라스마 검사 시장은 다양한 분야에서 마이코플라스마 오염을 감지하고 예방하기 위해 신뢰할 수 있고 정확하며 효율적인 도구와 서비스를 제공하는 것을 목표로 합니다. 이 시장에는 검사, 검증, 컨설팅과 같은 실험실 서비스와 함께 키트, 시약, 기기, 소프트웨어와 같은 다양한 제품이 포함됩니다. 주요 시장 촉진요인으로는 바이오의약품 및 세포 기반 치료에 대한 수요 증가, 마이코플라스마 오염 위험에 대한 인식 증가, 검사 기술의 발전 등을 들 수 있습니다. 엄격한 규제 요건으로 인해 강력한 검사 솔루션에 대한 필요성이 더욱 증가하고 있습니다. 그러나 높은 검사 비용, 표준화된 검사 방법의 부재, 숙련된 검사자 부족 등의 문제가 시장 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 지속적인 기술 혁신의 필요성, 위양성 및 교차 반응성 등의 문제에 대한 대응, 진화하는 수요에 대한 적응 등이 큰 도전과제로 대두되고 있습니다. 성장 기회로는 새로운 기술 개발, 새로운 지역 및 산업으로의 시장 진출, 다른 품질 관리 시스템과의 검사 통합, 디지털화 및 자동화 추세를 활용하여 효율성과 정확성을 향상시키는 것 등이 있습니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

마이코플라스마 검사 시장 : 제품 및 서비스별

마이코플라스마 검사 시장 : 방법별

마이코플라스마 검사 시장 : 용도별

마이코플라스마 검사 시장 : 최종사용자별

마이코플라스마 검사 시장 규모 : 지역별

경쟁 상황

주요 기업 개요

ksm
영문 목차

영문목차

Global Mycoplasma Testing Market size was valued at USD 829.6 million in 2022 and is poised to grow from USD 9110.23 million in 2023 to USD 1911.78 million by 2031, growing at a CAGR of 9.72% during the forecast period (2024-2031).

The mycoplasma testing market aims to deliver reliable, accurate, and efficient tools and services for detecting and preventing Mycoplasma contamination across various sectors. It includes a range of products such as kits, reagents, instruments, and software, alongside laboratory services like testing, validation, and consulting. Key drivers of the market include the rising demand for biopharmaceuticals and cell-based therapies, heightened awareness of mycoplasma contamination risks, and advancements in testing technologies. Stringent regulatory requirements further propel the need for robust testing solutions. However, challenges such as high testing costs, a lack of standardized methods, and limited skilled personnel hinder the market. Additionally, the need for continuous innovation, addressing issues like false results and cross-reactivity, and adapting to evolving demands pose significant challenges. Opportunities for growth include the development of new technologies, market expansion into new regions and industries, and integrating testing with other quality control systems, while leveraging trends in digitization and automation to improve efficiency and accuracy.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mycoplasma Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Mycoplasma Testing Market Segmental Analysis

Global Mycoplasma Testing Market is segmented by Product & Service, Technique, Application, End User, and Region. Based on Product & Service, the market is segmented into Assays, Kits, & Reagents (NAT Assays, Kits, & Reagents; Enzyme-Linked Immunosorbent Assays, Kits, & Reagents, Elimination Kits, Stains, Other Assays, Kits, & Reagents), Instruments, Services. Based on Technique, the market is segmented into Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay, Staining, Other Techniques. Based on Application, the market is segmented into Cell Line Testing, Virus Testing, End-Of-Production Cell Testing. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, Cell Banks & Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Mycoplasma Testing Market

As awareness of the risks and consequences associated with Mycoplasma contamination grows, so does the demand for Mycoplasma testing. Contamination can significantly impact experimental results, affecting the reliability of research findings and altering cellular behavior. Additionally, it poses health risks to researchers and patients, further underscoring the need for effective testing solutions to ensure accuracy and safety in various scientific and clinical settings.

Restraints in the Global Mycoplasma Testing Market

The high expense associated with mycoplasma testing products and services can pose a considerable obstacle for many customers, particularly in emerging markets or resource-limited environments. Costs can fluctuate based on the type of test, the complexity of the sample, and the test's sensitivity and specificity. Advanced methods, such as PCR-based assays or high-throughput sequencing, are especially costly and may be out of reach for some customers, further limiting accessibility.

Market Trends of the Global Mycoplasma Testing Market

The integration of Mycoplasma testing with other quality control and assurance systems, such as microbial identification, endotoxin testing, and bioburden testing, is increasingly common in the market. This trend enables customers to consolidate their testing processes, leading to more efficient workflows. By combining these tests, customers can achieve faster turnaround times and reduce overall testing costs, enhancing both operational efficiency and cost-effectiveness.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Mycoplasma Testing Market, By Product & Service

Mycoplasma Testing Market, By Technique

Mycoplasma Testing Market, By Application

Mycoplasma Testing Market, By End User

Mycoplasma Testing Market Size by Region

Competitive Landscape

Key Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기